Connect with us

Health

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2? – News-Medical.Net

A team of scientists from the USA recently developed a recombinant “Angiotensin converting enzyme 2 (ACE2) Triple Decoy” that can trap SARS-CoV-2 and prevent its…

Published

on

Article feature image

A team of scientists from the USA recently developed a recombinant “Angiotensin converting enzyme 2 (ACE2) Triple Decoy” that can trap severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent its propagation inside the host cell. They have reported that the decoy has high affinity for different mutants of the spike receptor-binding domain (RBD) known to significantly increase viral transmission. The study is currently available on the bioRxiv* preprint server.
Background
Since its…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending